Company news
Anixa Biosciences, Inc. news in 2022
Anixa Biosciences, Inc.'s news releases, calls and decks from 2022, newest first.
Anixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine
December 7, 2022
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium
November 7, 2022
Anixa Biosciences Announces Commencement of Phase 1b Trial of its Breast Cancer Vaccine at Cleveland Clinic
October 25, 2022
Anixa Biosciences Announces Presentation on Ovarian Cancer CAR-T Therapy Trial at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 9, 2022
Anixa Biosciences Announces Treatment of First Patient in its Ovarian Cancer CAR-T Clinical Trial
August 14, 2022
Anixa Biosciences Announces Notice of Allowance of Additional Patent on Breast Cancer Vaccine Technology
July 20, 2022
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
April 27, 2022
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase 1 Trial at Moffitt Cancer Center
March 29, 2022
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine
January 24, 2022
Decks in 2022
- Technical Presentation (September 2022)
Technical · 12 slides · Sep 29, 2022
- Investor Presentation (March 2022)
Investor deck · 27 slides · Mar 11, 2022